Legend Biotech Corp

Legend Biotech Corp (LEGN) shows zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, suggesting operational stability in the near term. However, low signal in a short window doesn't mean low risk; biotech companies face structural risks from equity dilution, clinical trial outcomes, and financing dependency that require deeper analysis. The full $49 Report extends coverage to 12 months of filing history, calculates dilution risk scores across financing rounds, maps 8-K context and officer movements, and surfaces AI-detected risk signals missed by standard screening. The full $49 Report adds dilution trajectory, 12-month red-flag history, financing runway analysis, and forward risk signals.